×
About 108,864 results

ALLMedicine™ Multiple Sclerosis Center

Research & Reviews  51,627 results

Association of VEGFA, TIMP-3, and IL-6 gene polymorphisms with predisposition to optic ...
https://doi.org/10.1080/13816810.2020.1839916
Ophthalmic Genetics; Punyte V, Vilkeviciute A et. al.

Oct 30th, 2020 - The etiology of the inflammatory ON is multifactorial. Much attention is paid to the inflammatory and immune processes that are likely to contribute to the demyelination and MS development. IL-6, VEGFA, and TIMP-3 genes are thought to be involved ...

Prevalence of seropositivity of selected herpesviruses in patients with multiple sclero...
https://doi.org/10.1186/s12883-020-01977-w
BMC Neurology; Kofahi RM, Kofahi HM et. al.

Oct 30th, 2020 - Multiple sclerosis (MS) is a neurological disease that is caused by an autoimmune response that results in the neuron's demyelination in the central nervous system. The exact etiology of MS is not clear; however, several environmental and genetic ...

Local functional connectivity of patients with acute and remitting multiple sclerosis: ...
https://doi.org/10.1097/MD.0000000000022860
Medicine Zhu Y, Huang M et. al.

Oct 30th, 2020 - Using Kendall's coefficient of concordance (KCC-) and Coherence (Cohe-) regional homogeneity (ReHo) to explore the alterations of brain local functional connectivity in acute and remitting relapsing-remitting multiple sclerosis (RRMS), and its cli...

Anti-Axl antibody treatment reduces the severity of experimental autoimmune encephalomy...
https://doi.org/10.1186/s12974-020-01982-3
Journal of Neuroinflammation; DuBois JC, Ray AK et. al.

Oct 30th, 2020 - Multiple sclerosis is an immune-mediated disease of the central nervous system (CNS) characterized by inflammation, oligodendrocytes loss, demyelination, and damaged axons. Tyro3, Axl, and MerTK belong to a family of receptor tyrosine kinases that...

BEST-MS: A prospective head-to-head comparative study of natalizumab and fingolimod in ...
https://doi.org/10.1177/1352458520969145
Multiple Sclerosis (Houndmills, Basingstoke, England); Cohen M, Mondot L et. al.

Oct 30th, 2020 - There are few head-to-head studies to compare highly active treatments in multiple sclerosis (MS). The aim of this study was to compare the effectiveness between natalizumab (NTZ) and fingolimod (FTY) in active relapsing-remitting MS. Best Escalat...

see more →

Guidelines  105 results

Vision Problems in Multiple Sclerosis.
https://doi.org/10.1016/j.apmr.2020.08.003
Archives of Physical Medicine and Rehabilitation; Costa SL, Pandey K et. al.

Sep 28th, 2020 - Vision Problems in Multiple Sclerosis.|2020|Costa SL,Pandey K,Hrdina J,Rondon M,Devos H,|

Serum neurofilament light as a biomarker in progressive multiple sclerosis.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7538221
Neurology Kapoor R, Smith KE et. al.

Jul 17th, 2020 - There is an unmet need in multiple sclerosis (MS) therapy for treatments to stop progressive disability. The development of treatments may be accelerated if novel biomarkers are developed to overcome the limitations of traditional imaging outcomes...

Practical Sleep Information for People With Multiple Sclerosis.
https://doi.org/10.1016/j.apmr.2020.03.009
Archives of Physical Medicine and Rehabilitation; Siengsukon C, Karahan AY et. al.

May 13th, 2020 - Practical Sleep Information for People With Multiple Sclerosis.|2020|Siengsukon C,Karahan AY,Strober L,|epidemiology,standards,diagnosis,epidemiology,therapy,

Immediate and Sustained Effects of Interventions for Changing Physical Activity in People with Multiple Sclerosis: Meta-Analysis of Randomized Controlled Trials
https://www.archives-pmr.org/article/S0003-9993(20)30217-3/pdf
Archives of Physical Medicine & Rehibilitation; Kim Y

Apr 24th, 2020 - To examine the immediate and sustained effects of interventions for changing physical activity behavior in people with multiple sclerosis (MS), and explore factors that might moderate intervention effects on physical activity behavior (e.g., inter...

Digital triage for people with multiple sclerosis in the age of COVID-19 pandemic
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7162735/
Neurol Sci.; Bonavita S

Apr 16th, 2020 - We propose a possible approach for the remote monitoring of infection risk in people with multiple sclerosis, especially those on immunosuppressant drugs, during COVID-19 pandemic. We developed a digital triage tool to be sent to patients to quick...

see more →

Drugs  343 results see all →

Clinicaltrials.gov  53,259 results

Association of VEGFA, TIMP-3, and IL-6 gene polymorphisms with predisposition to optic ...
https://doi.org/10.1080/13816810.2020.1839916
Ophthalmic Genetics; Punyte V, Vilkeviciute A et. al.

Oct 30th, 2020 - The etiology of the inflammatory ON is multifactorial. Much attention is paid to the inflammatory and immune processes that are likely to contribute to the demyelination and MS development. IL-6, VEGFA, and TIMP-3 genes are thought to be involved ...

Prevalence of seropositivity of selected herpesviruses in patients with multiple sclero...
https://doi.org/10.1186/s12883-020-01977-w
BMC Neurology; Kofahi RM, Kofahi HM et. al.

Oct 30th, 2020 - Multiple sclerosis (MS) is a neurological disease that is caused by an autoimmune response that results in the neuron's demyelination in the central nervous system. The exact etiology of MS is not clear; however, several environmental and genetic ...

Local functional connectivity of patients with acute and remitting multiple sclerosis: ...
https://doi.org/10.1097/MD.0000000000022860
Medicine Zhu Y, Huang M et. al.

Oct 30th, 2020 - Using Kendall's coefficient of concordance (KCC-) and Coherence (Cohe-) regional homogeneity (ReHo) to explore the alterations of brain local functional connectivity in acute and remitting relapsing-remitting multiple sclerosis (RRMS), and its cli...

Anti-Axl antibody treatment reduces the severity of experimental autoimmune encephalomy...
https://doi.org/10.1186/s12974-020-01982-3
Journal of Neuroinflammation; DuBois JC, Ray AK et. al.

Oct 30th, 2020 - Multiple sclerosis is an immune-mediated disease of the central nervous system (CNS) characterized by inflammation, oligodendrocytes loss, demyelination, and damaged axons. Tyro3, Axl, and MerTK belong to a family of receptor tyrosine kinases that...

BEST-MS: A prospective head-to-head comparative study of natalizumab and fingolimod in ...
https://doi.org/10.1177/1352458520969145
Multiple Sclerosis (Houndmills, Basingstoke, England); Cohen M, Mondot L et. al.

Oct 30th, 2020 - There are few head-to-head studies to compare highly active treatments in multiple sclerosis (MS). The aim of this study was to compare the effectiveness between natalizumab (NTZ) and fingolimod (FTY) in active relapsing-remitting MS. Best Escalat...

see more →

News  3,397 results

Tips for Conducting a Virtual Neurologic Exam
https://www.staging.medscape.com/viewarticle/938456

Oct 27th, 2020 - This transcript has been edited for clarity. Stephen Krieger, MD: Hi. I'm Dr Stephen Krieger, a neurologist at the Corinne Goldsmith Dickinson Center for Multiple Sclerosis at Mount Sinai in New York. I'm here today with my collaborator Erin to sh...

Vitamin D for COVID? We've Been Burned Before
https://www.staging.medscape.com/viewarticle/939759

Oct 27th, 2020 - Find the latest COVID-19 news and guidance in Medscape's Coronavirus Resource Center. This transcript has been edited for clarity. Welcome to Impact Factor, your weekly dose of commentary on a new medical study. I'm Dr F. Perry Wilson from the Yal...

Tips for Conducting a Virtual Neurologic Exam
https://www.medscape.com/viewarticle/938456

Oct 27th, 2020 - This transcript has been edited for clarity. Stephen Krieger, MD: Hi. I'm Dr Stephen Krieger, a neurologist at the Corinne Goldsmith Dickinson Center for Multiple Sclerosis at Mount Sinai in New York. I'm here today with my collaborator Erin to sh...

Newer DMTs More Effective vs Injectables in Pediatric MS
https://www.medscape.com/viewarticle/939952

Oct 27th, 2020 - Among patients with pediatric-onset relapsing-remitting multiple sclerosis (MS), newer disease-modifying therapies (DMTs) reduce clinical and radiological disease activity more effectively than older injectable therapies. Nevertheless, all DMTs re...

End of the Road for High-Dose Biotin in MS?
https://www.medscape.com/viewarticle/939866

Oct 26th, 2020 - High-dose biotin, a B vitamin used at lower doses as a food supplement, does not significantly improve disability or walking speed in patients with progressive multiple sclerosis, new research shows. For this reason, and because of the possibility...

see more →

Patient Education  133 results see all →